RadNet, Inc. Defined Contribution Plan, Cost
RadNet, Inc. (RDNT) reported Defined Contribution Plan, Cost of $3.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-02
- RadNet, Inc. defined contribution plan, cost for fiscal 2025 was $3.90M, a 8.33% increase from fiscal 2024.
- RadNet, Inc. defined contribution plan, cost for fiscal 2024 was $3.60M, a 9.09% increase from fiscal 2023.
- RadNet, Inc. defined contribution plan, cost for fiscal 2023 was $3.30M, a 10.00% increase from fiscal 2022.
- RadNet, Inc. defined contribution plan, cost for fiscal 2022 was $3.00M, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | $3.90M 10-K · filed 2026-03-02 | |
| 2024-12-31 | $3.60M 10-K · filed 2026-03-02 | |
| 2023-12-31 | $3.30M 10-K · filed 2025-03-03 | $0.00 10-K · filed 2024-02-29 |
| 2022-12-31 | $3.00M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $3.00M 10-K · filed 2022-03-01 | |
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |
| 2019-12-31 | $2.90M 10-K · filed 2021-03-16 | $3.00M 10-K · filed 2020-03-16 |
| 2018-12-31 | $2.60M 10-K · filed 2020-03-16 | |
| 2017-12-31 | $2.30M 10-K · filed 2019-03-18 | $2.50M 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |